Cite
HARVARD Citation
Leach, A. et al. (2022). Immunogenicity, otitis media, hearing impairment, and nasopharyngeal carriage 6-months after 13-valent or ten-valent booster pneumococcal conjugate vaccines, stratified by mixed priming schedules: PREVIX_COMBO and PREVIX_BOOST randomised controlled trials. Lancet infectious diseases. 22 (9), pp. 1374-1387. [Online].